Conexeu Sciences Inc. (CNXU)
$5.33+$0.71 (+15.31%) Latest session
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 405,000 | $162K |
| Option exercise | 5 | 1,702,500 | |
| Other acquisition / disposition | 2 | 435,216 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
9 Form 4 filings on record, the earliest from May 15, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jeffrey Nathan Sharpe - Director | Option exercise | Common Stock | 500,000 | $0.00 | $500 | |
| Jeffrey Nathan Sharpe - Director | Option exercise | Performance Warrants | 500,000 | $0.00 | - | |
| Lynn Sebastian Purcell - Director | Other | Common Stock | 217,608 | $2.30 | $500K | |
| Lynn Sebastian Purcell - Director | Other | Warrant | 217,608 | $0.00 | $218 | |
| Lynn Sebastian Purcell - Director | Open-market purchase | Common Stock | 202,500 | $0.80 | $162K | |
| Lynn Sebastian Purcell - Director | Open-market purchase | Warrant | 202,500 | $0.00 | $203 | |
| Lynn Sebastian Purcell - Director | Option exercise | Warrant | 202,500 | $0.80 | $162K | |
| Michael G. Wright - 10% Owner | Option exercise | Performance Warrants | 250,000 | $0.00 | - | |
| Michael G. Wright - 10% Owner | Option exercise | Common Stock | 250,000 | $0.00 | $250 | |
| Michael G. Wright - 10% Owner | Option exercise | Common Stock | 400,000 | $0.00 | $400 | |
| Michael G. Wright - 10% Owner | Option exercise | Performance Warrants | 400,000 | $0.00 | - | |
| Jeffrey Nathan Sharpe - Director | Option exercise | Common Stock | 500,000 | $0.00 | $500 | |
| Jeffrey Nathan Sharpe - Director | Option exercise | Performance Warrants | 500,000 | $0.00 | - | |
| Zbigniew Paul Lorenc - Director | Grant or award | Common Stock | 11,175 | $0.00 | - | |
| OnePointTwo Capital Ventures LLC - 10% Owner | Open-market purchase | Common Stock | 422,500 | $0.80 | $338K | |
| OnePointTwo Capital Ventures LLC - 10% Owner | Open-market sale | Warrant | 422,500 | $0.00 | $423 | |
| OnePointTwo Capital Ventures LLC - 10% Owner | Open-market purchase | Warrant | 422,500 | $0.00 | $423 | |
| Lynn Sebastian Purcell - Director | Open-market purchase | Common Stock | 422,500 | $0.80 | $338K | |
| Lynn Sebastian Purcell - Director | Open-market sale | Warrant | 422,500 | $0.00 | $423 | |
| Lynn Sebastian Purcell - Director | Open-market purchase | Warrant | 422,500 | $0.00 | $423 |
Conexeu Sciences Inc. (CNXU) had 4 insider filings in the last 90 days, with the most recent on 2026-09-15. The full record for CNXU runs to 9 Form 4 filings, the earliest from 2026-05-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of CNXU were filed in the last 90 days, totaling $162K.
No insider sales of CNXU were filed in the last 90 days. 2 sales are on record for this company.
This page tracks CNXU Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CNXU to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$COAGHemab Therapeutics Holdings, Inc.
$COCHEnvoy Medical, Inc.
$COCPCocrystal Pharma, Inc.
$CODXCo-Diagnostics, Inc.
$COGTCogent Biosciences, Inc.
$COLLCOLLEGIUM PHARMACEUTICAL, INC
$CONConcentra Group Holdings Parent, Inc.
$COOCOOPER COMPANIES, INC.
$CORTCORCEPT THERAPEUTICS INC
$COYACoya Therapeutics, Inc.Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
